Astellas Pharma Global Development Inc

General

Total Cases34

Active Cases9

Patents--

CourtsD. Delaware E.D. New York E.D. Pennsylvania

TypeOperating Company

Elite Ratings

PTAB

--

--

--

Ratings

Experience

Grade

Trend

DCT

L3

A

PTAB

L4

A

CAFC

L3

E

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
10/30/24	Astellas Pharma Inc v. Lupin Ltd 1:23-CV-00819 ( D. DE )	NOTICE OF SERVICE of Zydus Pharmaceuticals (USA) Inc.'s and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs' Notice of Deposition of Defendant Zydus Under Federal Rule of Civil Procedure 30(b)(6) filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc..(Stombaugh, Alexis) (Entered: 10/30/2024)
10/30/24	Astellas Pharma Inc v. Lupin Ltd 1:23-CV-00819 ( D. DE )	MEMORANDUM AND ORDER: The Parties Motions for Claim Construction (D.I. [110] and D.I. [111] ) are GRANTED. (See Order for further details.) Ordered by Judge Joseph F. Bataillon on 10/30/2024. (vfm) (Entered: 10/30/2024)
10/29/24	Astellas Pharma Inc v. Lupin Ltd 1:23-CV-00819 ( D. DE )	SO ORDERED, D.I. [361] Stipulation and Order Regarding Sample Chain of Custody filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc. Ordered by Judge Christopher J. Burke on 10/28/2024. (smg) (Entered: 10/29/2024)
10/28/24	Astellas Pharma Inc v. Lupin Ltd 1:23-CV-00819 ( D. DE )	STIPULATION and [Proposed] Order Regarding Sample Chain of Custody by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 10/28/2024)
10/24/24	Astellas Pharma Inc v. Lupin Ltd 1:23-CV-00819 ( D. DE )	NOTICE OF SERVICE of (1) Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s Responses to Plaintiffs' Fourth Set of Interrogatories (Nos. 11-22); (2) Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s Responses to Plaintiffs' First Set of Requests for Admission (Nos. 1-15); and (3) Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s Responses to Plaintiffs' [sic] Second Set of Requests for Production of Documents and Things (Nos. [sic] 8-22) filed by Lupin Ltd., Lupin Pharmaceuticals, Inc..(Haney, Megan) (Entered: 10/24/2024) NOTICE OF SERVICE of (1) Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s Responses to Plaintiffs' Fourth Set of Interrogatories (Nos. 11-22); (2) Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s Responses to Plaintiffs' First Set of Requests for Admission (Nos. 1-15); and (3) Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s Responses to Plaintiffs' [sic] Second Set of Requests for Production of Documents and Things (Nos. [sic] 8-22) filed by Lupin Ltd., Lupin Pharmaceuticals, Inc..(Haney, Megan) (Entered: 10/24/2024)
10/24/24	Astellas Pharma Inc v. Ascent Pharmaceuticals Inc 1:23-CV-00486 ( D. DE )	NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Ascent's Third Set of Interrogatories (No. 12), (2) Plaintiffs' Objections and Responses to Defendant Ascent's Third Requests for Production of Documents and Things (Nos. 30-32), (3) Plaintiffs' Objections and Responses to Defendant MSN's Third Set of Interrogatories (Nos. 7-9), and (4) Plaintiffs' Objections and Responses to Defendant MSN's Second Set of Requests for Production of Documents and Things (Nos. 19-24) filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Joyce, Alexandra) (Entered: 10/24/2024) NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Ascent's Third Set of Interrogatories (No. 12), (2) Plaintiffs' Objections and Responses to Defendant Ascent's Third Requests for Production of Documents and Things (Nos. 30-32), (3) Plaintiffs' Objections and Responses to Defendant MSN's Third Set of Interrogatories (Nos. 7-9), and (4) Plaintiffs' Objections and Responses to Defendant MSN's Second Set of Requests for Production of Documents and Things (Nos. 19-24) filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Joyce, Alexandra) (Entered: 10/24/2024)
10/24/24	Astellas Pharma Inc v. Ascent Pharmaceuticals Inc 1:23-CV-00486 ( D. DE )	NOTICE OF SERVICE of MSN's Objections to Plaintiffs' 30(b)(6) Deposition Notice filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc..(Dorsney, Kenneth) (Entered: 10/24/2024)
10/24/24	Astellas Pharma Inc v. Ascent Pharmaceuticals Inc 1:23-CV-00486 ( D. DE )	STIPULATION TO EXTEND TIME Close of Fact Discovery to November 7, 2024 - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 10/24/2024)
10/24/24	Astellas Pharma Inc v. Ascent Pharmaceuticals Inc 1:23-CV-00486 ( D. DE )	SO ORDERED, D.I. [115] STIPULATION TO EXTEND TIME Close of Fact Discovery to November 7, 2024 filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc. Ordered by Judge Christopher J. Burke on 10/24/2024. (smg) (Entered: 10/24/2024)
10/23/24	Astellas Pharma Inc v. Lupin Ltd 1:23-CV-00819 ( D. DE )	NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Lupin Limited and Lupin Pharmaceuticals, Inc.'s Third Set of Requests for Production (Nos. 3-6), (2) Plaintiffs' First Supplemental Objections and Responses to Defendants' Joint Interrogatories (Nos. 4-5), (3) Plaintiffs' Objections and Responses to Defendants' Joint Third of Interrogatories (Nos. 6-15), (4) Plaintiffs' Objections and Responses to Defendants' Joint Third Set of Requests for Production (Nos. 13-25) filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Silver, Daniel) (Entered: 10/23/2024) NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Lupin Limited and Lupin Pharmaceuticals, Inc.'s Third Set of Requests for Production (Nos. 3-6), (2) Plaintiffs' First Supplemental Objections and Responses to Defendants' Joint Interrogatories (Nos. 4-5), (3) Plaintiffs' Objections and Responses to Defendants' Joint Third of Interrogatories (Nos. 6-15), (4) Plaintiffs' Objections and Responses to Defendants' Joint Third Set of Requests for Production (Nos. 13-25) filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Silver, Daniel) (Entered: 10/23/2024)